2021
DOI: 10.1016/j.biomaterials.2020.120588
|View full text |Cite
|
Sign up to set email alerts
|

Photothermally triggered nitric oxide nanogenerator targeting type IV pili for precise therapy of bacterial infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
48
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 69 publications
(52 citation statements)
references
References 65 publications
3
48
0
Order By: Relevance
“…However, it is impractical to heat nanozymes by direct contact with external heat sources, especially for in vivo antibacterial applications [ 23 ]. To overcome these shortcomings, the combination of nanozyme-based catalytic therapy and photothermal therapy (PTT) is a promising approach [ 24 , 25 ]. PTT is an effective method that uses photothermal reagents to generate local high temperature to treat bacterial infections under near-infrared (NIR) light irradiation [ 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, it is impractical to heat nanozymes by direct contact with external heat sources, especially for in vivo antibacterial applications [ 23 ]. To overcome these shortcomings, the combination of nanozyme-based catalytic therapy and photothermal therapy (PTT) is a promising approach [ 24 , 25 ]. PTT is an effective method that uses photothermal reagents to generate local high temperature to treat bacterial infections under near-infrared (NIR) light irradiation [ 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%
“…Preferably, smart photothermal nanoparticles should penetrate deep and evenly over the depth of an infectious biofilm. Most of the targeting moieties involve specific pathogen-recognitions, such as type IV pili or type III secretion protein for targeting Pseudomonas aeruginosa [31,32], vancomycin [33][34][35], anti-protein A IgY [36], endolysins or other specific bacterial receptors for targeting S. aureus, including MRSA strains [37,38]. Ideal therapeutic approaches should be based on non-specific bacterial targeting, at least until pathogen identification has been done in order to save valuable time during life-threatening infections.…”
Section: Discussionmentioning
confidence: 99%
“…372 To address these shortcomings, researchers have designed artificial nanozymes for PTTcatalytic antibacterial therapy. [373][374][375] The PTT method employs photothermal reagents to induce a local high temperature under the irradiation of a near-infrared laser to inhibit bacterial infections. 376 However, the therapeutic effects of PTT-catalytic antibacterial therapy are still unsatisfactory owing to the weak catalytic activity of traditional nanozymes.…”
Section: Antibacterialmentioning
confidence: 99%